About AirSculpt Technologies, Inc. 
AirSculpt Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 19 Schemes (2.97%)
Foreign Institutions
Held by 26 Foreign Institutions (3.37%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
39 Million
(Quarterly Results - Mar 2026)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 179 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.72
-9.37%
2.18






